Physician

Christopher M Greene, MD

According to 2025 Medicare claims, Christopher Greene, MD (NPI: 1154308740) practices family practice in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Catoosa, GA. This provider's primary affiliated billing organization is MEMORIAL HEALTH PARTNERS FOUNDATION, INC (NPI: 1922053545; TIN: 030417049) and primary practice location at 30736-5168. Greene is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Greene's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 6,797 HCPCS/CPT codes, and received $136,374 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 16,561 prescription claims across 1,117 beneficiaries totaling $2,146,386 in drug costs, led by Jardiance (Empagliflozin). DME data shows 61 claims. Open Payments data shows 81 records totaling $1,423. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $640,665 to $2,146,386. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,405 and ending at $9,414.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	387	7,741	$115,572
2016	476	7,271	$145,308
2017	884	11,510	$225,142
2018	608	9,369	$178,546
2019	589	10,921	$183,971
2020	522	11,788	$147,426
2021	550	10,773	$160,144
2022	492	5,963	$110,304
2023	506	7,756	$123,874
2024	510	6,797	$136,374

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	663	13,337	$640,665
2016	761	14,085	$718,196
2017	899	15,685	$885,512
2018	960	14,884	$997,398
2019	968	15,362	$894,914
2020	956	15,160	$955,497
2021	1,027	14,957	$1,254,043
2022	1,094	15,393	$1,426,173
2023	1,115	15,683	$1,808,667
2024	1,117	16,561	$2,146,386

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	77	241	$6,168
2016	75	226	$9,638
2017	44	177	$5,197
2018	45	133	$2,343
2019	37	143	$4,029
2020	42	114	$2,255
2021	35	154	$3,762
2022	37	143	$4,479
2023	18	111	$5,761
2024	19	61	$6,103

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	461	927	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	162	218	$56
G0008	Administration of influenza virus vaccine	50	50	$30
36415	Insertion of needle into vein for collection of blood sample	466	873	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	324	341	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	347	17,195	$325,895
Farxiga	Dapagliflozin Propanediol	366	17,760	$310,531
Ozempic	Semaglutide	169	7,004	$207,898
Eliquis	Apixaban	207	9,026	$170,174
Mounjaro	Tirzepatide	147	4,650	$168,437

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	18	$5,501
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	19	29	$577
A4259	Lancets, per box of 100	N	N/R	14	$25

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$1,423	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher M. Greene, MD?

Tedicare shows public-source Medicare data for Christopher M. Greene, MD (NPI 1154308740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher M. Greene, MD have ACO affiliation data?

Christopher M. Greene, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Christopher M. Greene, MD?

Christopher M. Greene, MD is linked to MEMORIAL HEALTH PARTNERS FOUNDATION, INC (billing NPI 1922053545) in the available physician profile data.

Does Christopher M. Greene, MD have Open Payments data?

Christopher M. Greene, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.